Short answer
SUPERNUS PHARMACEUTICALS, INC. (SUPN) filed an 8-K current report with the SEC on October 15, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Merger approved: 48,249,532 votes for versus 235,601 against.
SUPERNUS PHARMACEUTICALS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Merger approved: 48,249,532 votes for versus 235,601 against
- Supernus becomes a wholly owned Indivior subsidiary after Merger Sub merger completion
- Executive merger compensation approved on advisory basis: 32,688,410 for versus 15,847,350 against
- Shareholder vote based on 58,224,143 shares outstanding as of September 4, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SUPERNUS PHARMACEUTICALS, INC. 8-K filings
Get the next SUPN 8-K as it lands
Follow SUPN for push alerts, or ask the research agent what this filing means.